Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.35 is in line with its 5-year average of 1.44, near the low end of its 5-year range (0.39–10.64).
As of the fiscal period ended Tuesday, June 30, 2026. 3.43% below its 12-month average of 1.40.
Reported quarterly quick ratio; no daily interpolation. Q4 FY2026 (2026-06-30): 1.35.
QUICK RATIO (ACID-TEST)
1.35
QUICK RATIO (ACID-TEST) AVG TTM
1.40
QUICK RATIO (ACID-TEST) AVG 3Y
1.14
QUICK RATIO (ACID-TEST) AVG 5Y
1.44
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-3.43%
CURRENT VS 3Y AVG
+18.81%
CURRENT VS 5Y AVG
-5.99%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-59.61%
vs the sector median at left
Intelligent Bio Solutions Inc.
Market Cap
$5.24M
Quick Ratio (Acid-Test)
1.35
TTM Avg
1.40
3Y Avg
1.14
5Y Avg
1.44
Market Cap
$5.22M
Quick Ratio (Acid-Test)
4.70
TTM Avg
11.62
3Y Avg
9.03
5Y Avg
8.72
Market Cap
$5.21M
Quick Ratio (Acid-Test)
1.84
TTM Avg
1.72
3Y Avg
1.97
5Y Avg
1.97
Market Cap
$5.21M
Quick Ratio (Acid-Test)
3.01
TTM Avg
3.95
3Y Avg
2.52
5Y Avg
4.28
Market Cap
$5.31M
Quick Ratio (Acid-Test)
2.77
TTM Avg
2.10
3Y Avg
1.65
5Y Avg
2.34
Market Cap
$5.32M
Quick Ratio (Acid-Test)
0.09
TTM Avg
0.18
3Y Avg
0.40
5Y Avg
0.95
Market Cap
$5.35M
Quick Ratio (Acid-Test)
10.60
TTM Avg
4.75
3Y Avg
13.37
5Y Avg
23.75
Market Cap
$5.12M
Quick Ratio (Acid-Test)
0.19
TTM Avg
0.06
3Y Avg
0.46
5Y Avg
2.58
Market Cap
$4.97M
Quick Ratio (Acid-Test)
1.12
TTM Avg
0.07
3Y Avg
0.07
5Y Avg
0.12
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intelligent Bio Solutions Inc. (INBS) | $5.24M | 1.35 | 1.40 | 1.14 | 1.44 |
| Pulmatrix, Inc. (PULM)vs › | $5.22M | 4.70 | 11.62 | 9.03 | 8.72 |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.21M | 1.84 | 1.72 | 1.97 | 1.97 |
| Alzamend Neuro Inc (ALZN)vs › | $5.21M | 3.01 | 3.95 | 2.52 | 4.28 |
| Soligenix, Inc. (SNGX)vs › | $5.31M | 2.77 | 2.10 | 1.65 | 2.34 |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.32M | 0.09 | 0.18 | 0.40 | 0.95 |
| Lexaria Bioscience Corp. (LEXX)vs › | $5.35M | 10.60 | 4.75 | 13.37 | 23.75 |
| Lunai Bioworks Inc. (LNAI)vs › | $5.12M | 0.19 | 0.06 | 0.46 | 2.58 |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $4.97M | 1.12 | 0.07 | 0.07 | 0.12 |
| Xenetic Biosciences, Inc. (XBIO)vs › | $4.86M | 7.43 | 7.85 | 10.06 | 11.10 |
Quick Ratio
1.35
Excludes inventory
Current Ratio
1.44
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.35 |
| 2026-03-31 | 1.98 |
| 2025-12-31 | 2.26 |
| 2025-09-30 | 0.76 |
| 2025-06-30 | 0.65 |
| 2025-03-31 | 0.97 |
| 2024-12-31 | 0.76 |
| 2024-09-30 | 1.42 |
| 2024-06-30 | 1.42 |
| 2024-03-31 | 1.87 |
| 2023-12-31 | 0.39 |
| 2023-09-30 | 0.49 |
| 2023-06-30 | 0.49 |
| 2023-03-31 | 1.19 |
| 2022-12-31 | 1.19 |
| 2022-09-30 | 2.33 |
| 2022-06-30 | 2.90 |
| 2022-03-31 | 3.51 |
| 2021-12-31 | 5.60 |
| 2021-09-30 | 4.94 |
| 2021-06-30 | 10.64 |
| 2021-03-31 | 17.12 |
| 2020-12-31 | 17.12 |
| 2020-09-30 | 0.49 |
| 2020-06-30 | 0.06 |
| 2020-03-31 | 0.01 |
| 2019-12-31 | 0.00 |
| 2019-09-30 | 0.44 |
| 2019-06-30 | 0.37 |
| 2019-03-31 | 0.34 |
| 2018-12-31 | 0.00 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.08 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 0.00 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
